This medicine can be used as an adjuvant treatment for mesopic and scotopic vision (hemeralopia) and myopia. This is a vasculoprotective ophthalmic medicine.
Secure payment
Fast delivery, careful packaging
Efficient customer service
The drug Difrarel E is indicated: adjunctive treatment of disorders of mesopic and scotopic vision (hemeralopia), myopia.
Oral use The tablets are to be swallowed without chewing them with a glass of water.
3 to 6 tablets per day. The treatment must be carried out by cure of 20 days per month, then be renewed if necessary.
The treatment must be taken by cure of 20 days per month, and renewed if necessary.
Comply with your doctor's advice.
The active substances are (For a coated tablet): Anthocyanosidic extract of blueberry 50,000 mg Alpha-tocopherol acetate (concentrate) - powder form ...... 50,000 mg
The other ingredients are: sucrose, gelatin, silicic acid, microcrystalline cellulose (Avicel PH 200), croscarmellose sodium (Acdisol), colloidal anhydrous silica (Aerosil 200), acacia, sucrose, corn starch, talc, titanium dioxide (E171) ), opaglos 6000.
Never take DIFRAREL E, coated tablet in the following case: · history of allergy to one of the constituents of the coated tablet.
It is best not to use Difrarel E during pregnancy. If you discover that you are pregnant during treatment, consult your doctor as only he can judge the need for continued treatment. The use of this medication should be avoided during breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine